Salek-Ardakani, S., Yang, W., Ding, S., Chen, S., Dominik, P. K., Stanfield, J., . . . Chaparro-Riggers, J. (2021). Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity. BMJ Publishing Group.
Style de citation Chicago (17e éd.)Salek-Ardakani, Shahram, et al. Dual Checkpoint Blockade of CD47 and PD-L1 Using an Affinity-tuned Bispecific Antibody Maximizes Antitumor Immunity. BMJ Publishing Group, 2021.
Style de citation MLA (8e éd.)Salek-Ardakani, Shahram, et al. Dual Checkpoint Blockade of CD47 and PD-L1 Using an Affinity-tuned Bispecific Antibody Maximizes Antitumor Immunity. BMJ Publishing Group, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.